Phialogics

Allschwil, Switzerland

Phialogics is focuses on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.

$549K raised

Oct 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Phialogics raised?

Phialogics has raised $549K in total funding. The most recent round was Grant. The last funding was announced in October 2023.

Who are Phialogics's investors?

Phialogics's investors include HTGF (High-Tech Gruenderfonds), BaseLaunch.

Where is Phialogics headquartered?

Phialogics is headquartered in Allschwil, Switzerland.

What does Phialogics do?

Phialogics is focuses on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.

What stage is Phialogics at?

Phialogics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 6, 2023.

MLA

"Phialogics — Funding & Investors." VCBacked, October 6, 2023, https://www.vcbacked.co/company/phialogics. Accessed July 1, 2026.

APA

VCBacked. (2023). Phialogics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/phialogics

Wikipedia (cite web)

{{cite web |title=Phialogics — Funding & Investors |url=https://www.vcbacked.co/company/phialogics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 6, 2023.